Fifth, Li H. et al. (2019) suggested that c-Met inhibitors up-regulate the expression of PD-L1 in HCC cells by suppressing GSK3B-mediated PD-L1 degradation and induce T-cell suppression and tumor evasion of the immune response. This evidence concerns the gene MET and neoplasm.